Merck KGaA: Changes in the Executive Board

Merck KGaA  / Key word(s): Change of Personnel

13.12.2010 07:30

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Darmstadt, December 13, 2010 - Merck KGaA announced today that Dr. Stefan
Oschmann (53) will become Member of the Executive Board and General Partner
of Merck KGaA. He succeeds Elmar Schnee, who leaves the company for
personal reasons. In line with the duties of his predecessor, Stefan
Oschmann will be responsible for both divisions Merck Serono and Consumer
Health Care and personally assume the lead of the Merck Serono division as
of January 1, 2011.

Dr. Kai Beckmann (45) will become Member of the Executive Board and General
Partner of Merck KGaA effective April 1, 2011. He will be responsible for
the newly created Executive Board position of Human Resources.


Phyllis Carter
Tel. +49 6151 72-7144




13.12.2010 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Merck KGaA
              Frankfurter Str. 250
              64293 Darmstadt
              Deutschland
Phone:        +49 (0)6151 72 - 3321
Fax:          +49 (0)6151 72 - 913321
E-mail:       investor.relations@merck.de
Internet:     www.merck.de
ISIN:         DE0006599905
WKN:          659990
Indices:      DAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
              Terminbörse EUREX; London, SIX
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------